HIV-1 genotyping provides antiretroviral susceptibility information for protease inhibitors (PI), reverse transcriptase inhibitors (NRTI, NNRTI), and integrase inhibitors (INI). Preferred test is HIV1 Genotype and Integrase Inhibitor Resistance by Sequencing (2009256).
Polymerase Chain Reaction/Sequencing
Lavender (EDTA) or Plasma Preparation Tube (PPT).
Separate from cells within 6 hours of collection. Transfer 5 mL plasma to ARUP Standard Transport Tubes and freeze immediately. (Min: 3 mL)
CRITICAL FROZEN. Separate specimens must be submitted when multiple tests are ordered.
Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 2 years
Performed by non-ARUP Laboratory
Procedure should be used for patients with documented HIV-1 infection and viral loads greater than 500 copies/mL.
87900; 87901; 87906
|Component Test Code*||Component Chart Name||LOINC|
|3001239||EER HIV-1 GenoSure PRIme||51969-4|
|3001240||HIV-1 GenoSure PRIme||80689-3|
|3001241||HIV-1 GenoSure PRIme Interpretation||62364-5|
|3002957||HIV-1 Pol Gene Amplicon Adequate||93047-9|
- HIV-1 Genotype
- POL Genotype
- Resistance Testing
- Retroviral Genotype